Q1 2026 Health Catalyst Inc Earnings Call Transcript
Key Points
- Health Catalyst Inc (HCAT) reported strong first-quarter results, exceeding expectations on both revenue and adjusted EBITDA.
- The company ended the quarter with a strong cash position, reflecting a $13.1 million increase in cash, cash equivalents, and short-term investments compared to December 31, 2025.
- Project NEXUS, a comprehensive operational and business restructuring initiative, is expected to generate annual run rate cost savings of approximately $30 million.
- The introduction of total bookings as a simplified operating metric provides a clear benchmark of success and aligns with investor feedback.
- Health Catalyst Inc (HCAT) is focusing on AI initiatives, leveraging 18 years of proprietary healthcare improvement data to enhance its competitive advantage.
- The company is experiencing revenue pressure due to its previous migration strategy, which has created a churn dynamic impacting 2026.
- Professional services revenue continues to decline as the company shifts toward a more technology-led model.
- Adjusted technology gross margin is affected by duplicate hosting costs and heavy data loading costs associated with client deployments.
- The company anticipates $30 million in at-risk ARR due to the migration from DAS to Ignite, with a significant portion expected to impact 2026 revenue.
- Health Catalyst Inc (HCAT) is undergoing significant restructuring, including a 9% reduction in headcount, which may create short-term operational challenges.
Welcome to the Health Catalyst first-quarter 2026 earnings conference call. (Operator Instructions)
I would now like to turn the call over to Stephanie St. Clair, Senior Vice President of Finance and Investor Relations.
Good afternoon, and welcome to Health Catalyst's earnings call for the first quarter of 2026, which ended March 31, 2026. My name is Stephanie Sinclair, Finance and Investor Relations Senior Vice President. With me on the call today are Ben Albert, our Chief Executive Officer; and Jason Alger, our Chief Financial Officer. A complete disclosure of our results can be found in our press release issued today, as well as in our related Form 8-K furnished to the SEC, both of which are available on the Investor Relations section of our website at ir.healthcatalyst.com. As a reminder, today's call is being recorded, and a replay will be available following the conclusion of the call.
During today's call, we will make forward-looking
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
